Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1497729628
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Washington St
Boston, MA, 02111
Phone (617) 636-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
697 services
Medicare patients, 2024
229
Average age 73
Drug cost, 2024
$675K
553 prescriptions
Company payments, 2023
$130
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina Anderlind was code 99215 (office e&m - established), 120 times for 62 patients. In total Christina Anderlind billed 697 services in 31 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 120 | 62 | $111.14 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 84 | 36 | $98.81 | $8,300 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 70 | 45 | $25.81 | $1,807 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 44 | $13.82 | $760 |
| 99291 Critical Care E&M | Facility | 55 | 16 | $175.60 | $9,658 |
| 99223 Hospital E&M - Initial | Facility | 50 | 49 | $144.26 | $7,213 |
| 94729 Pulmonary Function Testing | Facility | 36 | 35 | $7.04 | $253 |
| 94010 Pulmonary Function Testing | Facility | 33 | 32 | $6.70 | $221 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 15 | $65.62 | $2,034 |
| 94060 Pulmonary Function Testing | Facility | 21 | 20 | $7.58 | $159 |
| 99231 Hospital E&M - Subsequent | Facility | 16 | 11 | $41.00 | $656 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $107.87 | $1,726 |
| 94727 Pulmonary Function Testing | Facility | 15 | 15 | $9.08 | $136 |
| 99205 Office E&M - New | Facility | 14 | 14 | $151.74 | $2,124 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $68.23 | $887 |
By year: 2022 $41K for 421 services; 2023 $42K for 526 services; 2024 $53K for 697 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina Anderlind prescribed most often to Medicare patients was Breo Ellipta (Fluticasone/Vilanterol), with 50 prescriptions and refills. In total Christina Anderlind wrote 553 Medicare prescriptions that cost $675K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breo Ellipta Fluticasone/Vilanterol | 50 | 50 | Under 11 | $20K |
| Prednisone Generic | 47 | 74 | 16 | $492 |
| Incruse Ellipta Umeclidinium Bromide | 45 | 65 | Under 11 | $22K |
| Montelukast Sodium Generic | 36 | 88 | 13 | $561 |
| Mycophenolate Mofetil Generic | 35 | 60 | Under 11 | $3,535 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 33 | 39 | 13 | $1,117 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 31 | 41 | Under 11 | $26K |
| Ventolin Hfa Albuterol Sulfate | 25 | 28 | Under 11 | $1,631 |
| Ofev Nintedanib Esylate | 24 | 24 | Under 11 | $312K |
| Dulera Mometasone/Formoterol | 23 | 23 | Under 11 | $5,815 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 22 | 22 | Under 11 | $10K |
| Ethambutol Hcl Generic | 19 | 28 | Under 11 | $677 |
| Methotrexate Methotrexate Sodium | 12 | 31 | Under 11 | $521 |
| Sirturo Bedaquiline Fumarate | 12 | 12 | Under 11 | $52K |
| Arikayce Amikacin Liposomal/Neb.Accessr | 11 | 11 | Under 11 | $163K |
Brand drugs: 308 claims; generic drugs: 245 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Christina Anderlind $130 ($130 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $130.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.